Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network

Yohann Pilon,Merav Rokah,Joseph Seitlinger, Boris Sepesi,Roni F. Rayes,Jonathan Cools-Lartigue,Sara Najmeh,Christian Sirois,David Mulder,Lorenzo Ferri,Bassam Abdulkarim,Nicole Ezer,Richard Fraser,Sophie Camilleri-Broët,Pierre-Olivier Fiset, Annick Wong,Shelly Sud, Adrian Langleben,Jason Agulnik,Carmela Pepe

Clinical Lung Cancer（2023）

引用 0|浏览7

暂无评分

摘要

•Large-scale neoadjuvant therapy program for non-small cell lung cancer is feasible•Peri-operative outcomes are similar in upfront surgery vs neoadjuvant in NSCLC•Surgery is safe among neoadjuvant-treated resectable NSCLC

查看译文

关键词

Lung cancer,Neoadjuvant therapy,Surgical outcomes,Personalized medicine,Thoracic oncology

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要